FR2829392B1 - Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire - Google Patents

Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire

Info

Publication number
FR2829392B1
FR2829392B1 FR0111627A FR0111627A FR2829392B1 FR 2829392 B1 FR2829392 B1 FR 2829392B1 FR 0111627 A FR0111627 A FR 0111627A FR 0111627 A FR0111627 A FR 0111627A FR 2829392 B1 FR2829392 B1 FR 2829392B1
Authority
FR
France
Prior art keywords
crmps
dysfunction
medicament
manufacture
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0111627A
Other languages
English (en)
Other versions
FR2829392A1 (fr
Inventor
Pascale Giraudon
Marie Francoise Belin
Christophe Malcus
Jean Christophe Antoine
Jerome Honnorat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0111627A priority Critical patent/FR2829392B1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to EP02774915A priority patent/EP1435993B1/fr
Priority to US10/488,554 priority patent/US7820375B2/en
Priority to CA002461692A priority patent/CA2461692A1/fr
Priority to AT02774915T priority patent/ATE517629T1/de
Priority to JP2003526426A priority patent/JP4499414B2/ja
Priority to ES02774915T priority patent/ES2369354T3/es
Priority to PCT/FR2002/003056 priority patent/WO2003022298A2/fr
Priority to AU2002341090A priority patent/AU2002341090A1/en
Publication of FR2829392A1 publication Critical patent/FR2829392A1/fr
Application granted granted Critical
Publication of FR2829392B1 publication Critical patent/FR2829392B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0111627A 2001-09-07 2001-09-07 Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire Expired - Fee Related FR2829392B1 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FR0111627A FR2829392B1 (fr) 2001-09-07 2001-09-07 Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire
US10/488,554 US7820375B2 (en) 2001-09-07 2002-09-09 Use of a protein of the CRMP family for treating diseases related to the immune system
CA002461692A CA2461692A1 (fr) 2001-09-07 2002-09-09 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire
AT02774915T ATE517629T1 (de) 2001-09-07 2002-09-09 Verwendung eines proteins der crmp familie zur behandlung von krankheiten des immunsystems
EP02774915A EP1435993B1 (fr) 2001-09-07 2002-09-09 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire
JP2003526426A JP4499414B2 (ja) 2001-09-07 2002-09-09 免疫系に関する疾病を治療するためのｃｒｍｐファミリーのタンパク質の使用
ES02774915T ES2369354T3 (es) 2001-09-07 2002-09-09 Utilización de una proteina de la familia de las crmps para el tratamiento de enfermedades ligadas al sistema inmunitario.
PCT/FR2002/003056 WO2003022298A2 (fr) 2001-09-07 2002-09-09 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire
AU2002341090A AU2002341090A1 (en) 2001-09-07 2002-09-09 Use of a protein of the crmp family for treating diseases related to the immune system

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0111627A FR2829392B1 (fr) 2001-09-07 2001-09-07 Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire

Publications (2)

Publication Number Publication Date
FR2829392A1 FR2829392A1 (fr) 2003-03-14
FR2829392B1 true FR2829392B1 (fr) 2005-09-16

Family

ID=8867087

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0111627A Expired - Fee Related FR2829392B1 (fr) 2001-09-07 2001-09-07 Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire

Country Status (2)

Country Link
ES (1) ES2369354T3 (fr)
FR (1) FR2829392B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2759701B1 (fr) * 1997-02-19 1999-06-04 Inst Nat Sante Rech Med Utilisation des proteines ulip dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques
FR2805540B1 (fr) * 2000-02-29 2004-04-09 Inst Nat Sante Rech Med Nouvelle proteine ulip humaine et son utilisation dans le diagnostic et la therapie des cancers et des syndromes neurologiques paraneoplasiques

Also Published As

Publication number Publication date
FR2829392A1 (fr) 2003-03-14
ES2369354T3 (es) 2011-11-29

Similar Documents

Publication Publication Date Title
EP1434594A4 (fr) Analogues de cyclosporine pour le traitement de maladies auto-immunes
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
FR2840804B1 (fr) Systeme pour le traitement de l'obesite et implant pour un tel systeme
DZ3500A1 (fr) Derives de phenethanolamine pour le traitement de maladies respiratoires
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0200994A3 (en) Remedies for immunological diseases
EP1482972A4 (fr) Traitement des troubles immunologiques au moyen des anticorps anti-cd30
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
EP1311261A4 (fr) Medicaments pour le traitement chimiotherapeutique de maladies
NO20041882L (no) Fremgangsmater for behandling av okulare neovaskulaere sykdommer.
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
EP1404343A4 (fr) Combinaisons therapeutiques pour le traitement des carences hormonales
EP1463527A4 (fr) Utilisation de gammaglobuline pour le traitement de maladies d'origine immunologique
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
EP1618411A4 (fr) Rejet de diffusion pour systemes d'imagerie medicale composite
FR13C0044I2 (fr) Utilisation de dihydroimidazolones pour le traitement de l'epilepsie canine
FR2826232B1 (fr) Releveur d'epis pour systemes de fauchage de machines de recolte
EP1448193A4 (fr) Composes therapeutiques pour le traitement d'etats dyslipidemiques
EE200200693A (et) Interferoon hulgiskleroosi raviks
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
AU2002254947A1 (en) Kappa opiate agonists for the treatment of bladder diseases
FR2829392B1 (fr) Utilisation de crmps pour la fabrication d'un medicament destine a traiter les maladies liees a un dysfonctionnement du systeme immunitaire

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090529